EX-10.6 7 dex106.htm MASTER DEVELOPMENT SERVICES AGREEMENT Portions of this exhibit marked [*] have been granted confidential treatment. MASTER DEVELOPMENT SERVICES AGREEMENTMaster Development Services Agreement • May 5th, 2020 • North Carolina
THIS MASTER DEVELOPMENT SERVICES AGREEMENT (the “Agreement”) is made and entered into as of June 14, 2010 (the “Effective Date”) by and between PPD DEVELOPMENT, LP, a Texas limited partnership, with its principal executive offices located at 929 North Front Street, Wilmington, North Carolina 28401 (“PPD”), and FURIEX PHARMACEUTICALS, INC., a Delaware corporation with its principal executive offices located at 3900 Paramount Parkway, Suite 150, Morrisville, North Carolina 27560 (“Sponsor”).
MASTER DEVELOPMENT SERVICES AGREEMENTMaster Development Services Agreement • October 3rd, 2022 • Yumanity Therapeutics, Inc. • Pharmaceutical preparations • New York
This Master Development Services Agreement (this “MDSA”) is made and entered into as of the date of last signature below (the “Effective Date”) by and between Kineta, Inc., a Washington corporation having its principal place of business at 219 Terry Avenue North, Suite 300, Seattle, WA 98109 (“Client”), and Samsung Biologics Co., Ltd., a Korean corporation having its principal place of business at 300, Songdo bio-daero, Yeonsu-gu, Incheon, 21987, Republic of Korea (“SBL”). Client and SBL are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
EXHIBIT 10.9Master Development Services Agreement • February 2nd, 2001 • Netsol International Inc • Services-prepackaged software • California
